RPRX

NASDAQStock

Royalty Pharma plc

$46.12-0.57 (-1.22%)

52-Week Range

$30.85
$47.48

Key Stats

Market Cap

19.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Volume

2.4M

Avg Volume

3.3M

Performance

1M

+3.66%

3M

+19.05%

6M

+30.50%

YTD

+18.04%

1Y

+40.36%

3Y

+38.12%

5Y

-2.07%

Price Chart

ETF Exposure

RPRX is held by 188 ETFs

ETFFund NameWeight
JKDiShares Morningstar U.S. Equity ETF0.03%
SCHBSchwab U.S. Broad Market ETF0.03%
VONEVanguard Russell 1000 ETF0.03%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.03%
KOKUXtrackers MSCI Kokusai Equity ETF0.03%
SCHZSchwab U.S. Aggregate Bond ETF0.03%
TOKiShares MSCI Kokusai ETF0.02%
VTHRVanguard Russell 3000 ETF0.02%
PRFInvesco RAFI US 1000 ETF0.02%
URTHiShares MSCI World ETF0.02%
BALIiShares U.S. Large Cap Premium Income Active ETF0.02%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.02%
ACWIiShares MSCI ACWI ETF0.02%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.02%
FNDBSchwab Fundamental U.S. Broad Market Index ETF0.02%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.02%
SFYSoFi Select 500 ETF0.02%
SPUTInnovator Equity Premium Income – Daily PutWrite ETF0.01%
VTVanguard Total World Stock ETF0.01%
QUSState Street SPDR MSCI USA StrategicFactors ETF0.01%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.01%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.01%
QWLDState Street SPDR MSCI World StrategicFactors ETF0.01%
ITDGiShares LifePath Target Date 2055 ETF0.01%
ITDHiShares LifePath Target Date 2060 ETF0.01%
ITDIiShares LifePath Target Date 2065 ETF0.01%
ITDJiShares LifePath Target Date 2070 ETF0.01%
ITDFiShares LifePath Target Date 2050 ETF0.01%
ITDDiShares LifePath Target Date 2040 ETF0.01%
ITDEiShares LifePath Target Date 2045 ETF0.01%
CPIIQ Real Return ETF0.01%
ITDCiShares LifePath Target Date 2035 ETF0.01%
ITDBiShares LifePath Target Date 2030 ETF0.00%
IALTiShares Systematic Alternatives Active ETF0.00%
INROiShares U.S. Industry Rotation Active ETF0.00%
IRTRiShares LifePath Retirement ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
LVHBInnovator Laddered Allocation Power Buffer ETF0.00%
PreviousPage 4 of 4

About RPRX ETF Exposure

Royalty Pharma plc (RPRX) is held by 188 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 19.8B, RPRX is a widely held institutional stock. The stock currently trades at $46.12. Investors can gain exposure to RPRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RPRX, sorted by portfolio weight.